BIOMAT Database Logo BIOMAT Database Logo

Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors. 1988

H Yamazaki, and Y Fukui, and Y Ueyama, and N Tamaoki, and T Kawamoto, and S Taniguchi, and M Shibuya
Department of Genetics, University of Tokyo, Japan.

By using Southern blot analysis, we found that in two cases of human glioblastoma multiforme, cells carried amplified c-erbB genes which bore short deletion mutations within the ligand-binding domain of the epidermal growth factor (EGF) receptor. The products of these mutated c-erbB genes were about 30 kilodalton (kDa) smaller than the normal 170-kDa EGF receptor, and the tumor cell membrane fractions containing the 140-kDa abnormal EGF receptor showed a significant elevation of tyrosine kinase activity without its ligand. In view of the similarity to the activated viral and cellular erbB genes in the avian system, these mutated and overexpressed EGF receptors might play a role in the onset or development of human glioblastoma cells.

UI MeSH Term Description Entries
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D011519 Proto-Oncogenes Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc. Proto-Oncogene,Proto Oncogene,Proto Oncogenes
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002872 Chromosome Deletion Actual loss of portion of a chromosome. Monosomy, Partial,Partial Monosomy,Deletion, Chromosome,Deletions, Chromosome,Monosomies, Partial,Partial Monosomies
D005784 Gene Amplification A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication. Amplification, Gene
D005796 Genes A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms. Cistron,Gene,Genetic Materials,Cistrons,Genetic Material,Material, Genetic,Materials, Genetic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

H Yamazaki, and Y Fukui, and Y Ueyama, and N Tamaoki, and T Kawamoto, and S Taniguchi, and M Shibuya
Epidermal growth factor receptor gene and c-erbB-2 gene amplification in ovarian cyst fluid.
December 1996, Obstetrics and gynecology,
H Yamazaki, and Y Fukui, and Y Ueyama, and N Tamaoki, and T Kawamoto, and S Taniguchi, and M Shibuya
Amplification of the c-met, c-erbB-2 and epidermal growth factor receptor gene in human gastric cancers: correlation to clinical features.
January 1998, Oncology,
H Yamazaki, and Y Fukui, and Y Ueyama, and N Tamaoki, and T Kawamoto, and S Taniguchi, and M Shibuya
Epidermal growth factor receptor in human brain tumors.
January 1992, Journal of endocrinological investigation,
H Yamazaki, and Y Fukui, and Y Ueyama, and N Tamaoki, and T Kawamoto, and S Taniguchi, and M Shibuya
Analysis of epidermal growth factor receptor gene amplification and alteration in stereotactic biopsies of brain tumors.
April 1995, Neurosurgery,
H Yamazaki, and Y Fukui, and Y Ueyama, and N Tamaoki, and T Kawamoto, and S Taniguchi, and M Shibuya
Amplification of the epidermal growth factor receptor gene in human gliomas.
January 1991, Anticancer research,
H Yamazaki, and Y Fukui, and Y Ueyama, and N Tamaoki, and T Kawamoto, and S Taniguchi, and M Shibuya
Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
July 2005, The Journal of pathology,
H Yamazaki, and Y Fukui, and Y Ueyama, and N Tamaoki, and T Kawamoto, and S Taniguchi, and M Shibuya
[C-erbB-2 oncogene amplification in breast cancer in correlation to steroid and epidermal growth factor receptor].
January 1992, Zentralblatt fur Gynakologie,
H Yamazaki, and Y Fukui, and Y Ueyama, and N Tamaoki, and T Kawamoto, and S Taniguchi, and M Shibuya
Expression of epidermal growth factor receptors and c-erbB-2 proteins in human astrocytic tumors.
July 1997, The Kaohsiung journal of medical sciences,
H Yamazaki, and Y Fukui, and Y Ueyama, and N Tamaoki, and T Kawamoto, and S Taniguchi, and M Shibuya
Coexpression of epidermal growth factor receptor protein and c-erbB-2 oncoprotein in human astrocytic tumors. An immunohistochemical study.
November 1994, Zentralblatt fur Pathologie,
H Yamazaki, and Y Fukui, and Y Ueyama, and N Tamaoki, and T Kawamoto, and S Taniguchi, and M Shibuya
Detection of epidermal growth-factor receptor and C-erbb-2 gene amplification in transitional-cell bladder-carcinoma using the differential PCR technique.
June 1994, International journal of oncology,
Copied contents to your clipboard!